Functional Bioactive Supplement Effect in Lost Weight Treatment (ALIBIRDII)

This is an interventional treatment trial for Obesity and Overweight focused on measuring Clinical trials, Adult, Women, Functional food, Dietary Supplements, Overweight, Obese, Absorptiometry, Dual X-Ray, Rosmarinus, Oligosaccharides, Lactulose, Bioactive peptide Read More

Inclusion Criteria:

• Women from 45 to 75 years old;
• Overweight (IMC ≥25<30 Kg/m2) or obese (IMC ≥30<35 Kg/m2) volunteers
• Signed informed consent.

Exclusion Criteria:

• Subjects with drug consumption (lipid-lowering, oral hypoglycemic agents and / or hypertensive) in less than one month period;
• Subjects with Diabetes Mellitus insulin dependent;
• Individuals that stop smoking in the next 12 weeks (during the study);
• Subjects with increased alcohol consumption (> 1 glass of vine);
• Subjects that consume drugs, vitamins, minerals, prebiotics or/and probiotics that interfere with the body's response to the extracts in the 2 weeks before to baseline;
• Subjects with drugs consumption special diet due to disease as celiac disease, chronic renal failure, etc;
• Subjects with disorders associated with eating behaviour;
• Subjects with drugs or supplements consumption to weight lost;
• Subjects with physical problems complying with the recommendations of physical activity and diet indicated;
• Subjects who refuse to perform the indicated dietary changes throughout the study;
• Subjects with diseases that could be involucrate in weight lost (not controlled hypothyroidism, serious psychiatric illness, etc.);
• Subjects with mental disease or low cognitive function;
• Subjects with severe diseases (hepatic, kidney, cancer…);
• Pregnant women or lactating;
• Subjects with physical problems complying with the recommendations of physical activity.
• Subjects with intensive physical activity;